Erratum: Transmembrane TNF-α Density, But Not Soluble TNF-α Level, is Associated with Primary Response to Infliximab in Inflammatory Bowel Disease

Míreanna Comhchosúla

• Transmembrane TNF-α Density, but not Soluble TNF-α Level, is Associated with Primary Response to Infliximab in Inflammatory Bowel Disease
  le: Amini Kadijani, Azade, et al.
  Foilsithe: (2017)
• An increased Bax/Bcl-2 ratio in circulating inflammatory cells predicts primary response to infliximab in inflammatory bowel disease patients
  le: Aghdaei, Hamid Asadzadeh, et al.
  Foilsithe: (2018)
• The role of serum calprotectin as a novel biomarker in inflammatory bowel diseases: a review study
  le: Azramezani Kopi, Tayebeh, et al.
  Foilsithe: (2019)
• Evaluation of tumor necrosis factor (TNF)-α mRNA expression level and the rs1799964 polymorphism of the TNF-α gene in peripheral mononuclear cells of patients with inflammatory bowel diseases
  le: Nourian, Mahyar, et al.
  Foilsithe: (2017)
• Inducible nitric oxide synthase as a potential blood-based biomarker in inflammatory bowel diseases
  le: Baranipour, Saeed, et al.
  Foilsithe: (2018)